Keep Different Weight Loss Meds Straight During Transitions of Care

Please see the February 2020 FDA recommendation to remove Belviq and Belviq XR from the market.

New versions of phentermine (Lomaira, loh-MER-uh) and lorcaserin (Belviq XR) will add to the plethora of weight loss meds.

Over one in three Americans are obese...and many are turning to medications to help lose weight.

Develop transitions-of-care plans for these meds.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals